KRA-533
KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.
Product Specifications
CAS Number
10161-87-2
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kra-533.html
Concentration
10mM
Purity
98.73
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(O)C1=CC=C(CCCCNC(CBr)=O)C=C1
Molecular Formula
C13H16BrNO3
Molecular Weight
314.18
References & Citations
[1]Xu K, et al. Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy [published correction appears in Mol Cancer. 2020 May 20;19 (1) :93]. Mol Cancer. 2019;18 (1) :85. Published 2019 Apr 10.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC401450 20 µg
Rab4 (RAB4A) (NM_004578) Human Over-expression Lysate
Sign In for Pricing
View Details 
![BMF Mouse Monoclonal Antibody [Clone ID: OTI5H2]](https://cdn.genprice.uk/products/937/68dd18b9061270361e9080d7/imageurl/cf807512.webp)